DLBS1425

DRUG2 trials

Sponsors

Dexa Medica Group

Conditions

Breast Cancer

Phase 2

Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast Cancer

TerminatedNCT01006785

Dexa Medica GroupBreast Cancer

Start: 2009-08-31End: 2012-03-31Updated: 2012-10-18

Efficacy and Safety of DLBS1425 as Neoadjuvant in Stage II or III Breast Cancer Patients

CompletedNCT01433562

Dexa Medica GroupBreast Cancer

Start: 2011-08-31End: 2012-11-30Updated: 2013-05-13